FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2488396268> ?p ?o ?g. }

• W2488396268 endingPage "788" @default.
• W2488396268 startingPage "778" @default.
• W2488396268 abstract "Abstract Purpose: Lung adenocarcinomas with mutations in the EGFR have unprecedented initial responses to targeted therapy against the EGFR. Over time, however, these tumors invariably develop resistance to these drugs. We set out to investigate alternative treatment approaches for these tumors. Experimental Design: To investigate the immunologic underpinnings of EGFR-mutant lung adenocarcinoma, we utilized a bitransgenic mouse model in which a mutant human EGFR gene is selectively expressed in the lungs. Results: EGFR oncogene–dependent progression and remission of lung adenocarcinoma was respectively dependent upon the expansion and contraction of alveolar macrophages, and the mechanism underlying macrophage expansion was local proliferation. In tumor-bearing mice, alveolar macrophages downregulated surface expression of MHC-II and costimulatory molecules; increased production of CXCL1, CXCL2, IL1 receptor antagonist; and increased phagocytosis. Depletion of alveolar macrophages in tumor-bearing mice resulted in reduction of tumor burden, indicating a critical role for these cells in the development of EGFR-mutant adenocarcinoma. Treatment of mice with EGFR-targeting clinical drugs (erlotinib and cetuximab) resulted in a significant decrease in alveolar macrophages in these mice. An activated alveolar macrophage mRNA signature was dominant in human EGFR-mutant lung adenocarcinomas, and the presence of this alveolar macrophage activation signature was associated with unfavorable survival among patients undergoing resection for EGFR-mutant lung adenocarcinoma. Conclusions: Because of the inevitability of failure of targeted therapy in EGFR-mutant non-small cell lung cancer (NSCLC), these data suggest that therapeutic strategies targeting alveolar macrophages in EGFR-mutant NSCLC have the potential to mitigate progression and survival in this disease. Clin Cancer Res; 23(3); 778–88. ©2016 AACR." @default.
• W2488396268 created "2016-08-23" @default.
• W2488396268 creator A5003985388 @default.
• W2488396268 creator A5021197073 @default.
• W2488396268 creator A5023175421 @default.
• W2488396268 creator A5034001543 @default.
• W2488396268 creator A5037470251 @default.
• W2488396268 creator A5045600892 @default.
• W2488396268 creator A5047708097 @default.
• W2488396268 creator A5065386057 @default.
• W2488396268 creator A5074452869 @default.
• W2488396268 date "2017-01-31" @default.
• W2488396268 modified "2023-10-18" @default.
• W2488396268 title "Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages" @default.
• W2488396268 cites W1606413143 @default.
• W2488396268 cites W1665146230 @default.
• W2488396268 cites W1969057487 @default.
• W2488396268 cites W1973433801 @default.
• W2488396268 cites W1976556343 @default.
• W2488396268 cites W1985987855 @default.
• W2488396268 cites W1986412478 @default.
• W2488396268 cites W1999178796 @default.
• W2488396268 cites W2005576626 @default.
• W2488396268 cites W2008621673 @default.
• W2488396268 cites W2010263122 @default.
• W2488396268 cites W2019179700 @default.
• W2488396268 cites W2027146979 @default.
• W2488396268 cites W2043991982 @default.
• W2488396268 cites W2058648826 @default.
• W2488396268 cites W2061123122 @default.
• W2488396268 cites W2061631577 @default.
• W2488396268 cites W2063270450 @default.
• W2488396268 cites W2070011883 @default.
• W2488396268 cites W2072114397 @default.
• W2488396268 cites W2074364115 @default.
• W2488396268 cites W2081801534 @default.
• W2488396268 cites W2084418462 @default.
• W2488396268 cites W2093705034 @default.
• W2488396268 cites W2096616470 @default.
• W2488396268 cites W2101327682 @default.
• W2488396268 cites W2106426363 @default.
• W2488396268 cites W2106631163 @default.
• W2488396268 cites W2113088269 @default.
• W2488396268 cites W2116376943 @default.
• W2488396268 cites W2118135682 @default.
• W2488396268 cites W2119444855 @default.
• W2488396268 cites W2126181231 @default.
• W2488396268 cites W2130819559 @default.
• W2488396268 cites W2134487724 @default.
• W2488396268 cites W2143859186 @default.
• W2488396268 cites W2145040145 @default.
• W2488396268 cites W2149067734 @default.
• W2488396268 cites W2149142217 @default.
• W2488396268 cites W2151832198 @default.
• W2488396268 cites W2155354546 @default.
• W2488396268 cites W2157778803 @default.
• W2488396268 cites W2162246648 @default.
• W2488396268 cites W2162981791 @default.
• W2488396268 cites W2170989872 @default.
• W2488396268 cites W2206669969 @default.
• W2488396268 cites W4242648511 @default.
• W2488396268 cites W4242743062 @default.
• W2488396268 doi "https://doi.org/10.1158/1078-0432.ccr-15-2597" @default.
• W2488396268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27496865" @default.
• W2488396268 hasPublicationYear "2017" @default.
• W2488396268 type Work @default.
• W2488396268 sameAs 2488396268 @default.
• W2488396268 citedByCount "35" @default.
• W2488396268 countsByYear W24883962682017 @default.
• W2488396268 countsByYear W24883962682018 @default.
• W2488396268 countsByYear W24883962682019 @default.
• W2488396268 countsByYear W24883962682020 @default.
• W2488396268 countsByYear W24883962682021 @default.
• W2488396268 countsByYear W24883962682022 @default.
• W2488396268 countsByYear W24883962682023 @default.
• W2488396268 crossrefType "journal-article" @default.
• W2488396268 hasAuthorship W2488396268A5003985388 @default.
• W2488396268 hasAuthorship W2488396268A5021197073 @default.
• W2488396268 hasAuthorship W2488396268A5023175421 @default.
• W2488396268 hasAuthorship W2488396268A5034001543 @default.
• W2488396268 hasAuthorship W2488396268A5037470251 @default.
• W2488396268 hasAuthorship W2488396268A5045600892 @default.
• W2488396268 hasAuthorship W2488396268A5047708097 @default.
• W2488396268 hasAuthorship W2488396268A5065386057 @default.
• W2488396268 hasAuthorship W2488396268A5074452869 @default.
• W2488396268 hasBestOaLocation W24883962681 @default.
• W2488396268 hasConcept C121608353 @default.
• W2488396268 hasConcept C126322002 @default.
• W2488396268 hasConcept C142724271 @default.
• W2488396268 hasConcept C202751555 @default.
• W2488396268 hasConcept C203014093 @default.
• W2488396268 hasConcept C2776256026 @default.
• W2488396268 hasConcept C2778087573 @default.
• W2488396268 hasConcept C2779244956 @default.
• W2488396268 hasConcept C2779438470 @default.
• W2488396268 hasConcept C2781182431 @default.
• W2488396268 hasConcept C2781230642 @default.
• W2488396268 hasConcept C502942594 @default.

• next